Sartorius Stedim Biotech SA
PAR:DIM
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
145.35
280
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA
Cash & Cash Equivalents
Sartorius Stedim Biotech SA
Cash & Cash Equivalents Peer Comparison
PCA
ALECR
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sartorius Stedim Biotech SA
PAR:DIM
|
Cash & Cash Equivalents
€454.1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
78%
|
CAGR 10-Years
27%
|
|
|
Pcas SA
PAR:PCA
|
Cash & Cash Equivalents
€266k
|
CAGR 3-Years
-67%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
-27%
|
|
|
Eurofins-Cerep SA
PAR:ALECR
|
Cash & Cash Equivalents
€9.3m
|
CAGR 3-Years
45%
|
CAGR 5-Years
28%
|
CAGR 10-Years
-2%
|
See Also
What is Sartorius Stedim Biotech SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
454.1m
EUR
Based on the financial report for Jun 30, 2024, Sartorius Stedim Biotech SA's Cash & Cash Equivalents amounts to 454.1m EUR.
What is Sartorius Stedim Biotech SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
27%
Over the last year, the Cash & Cash Equivalents growth was 313%. The average annual Cash & Cash Equivalents growth rates for Sartorius Stedim Biotech SA have been 21% over the past three years , 78% over the past five years , and 27% over the past ten years .
You don't have any saved screeners yet
